MYELOID NEOPLASM
Clinical trials for MYELOID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOID NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for children with rare, treatment-related cancers
Disease control OngoingThis study is testing the drug CPX-351 in patients under 22 years old who have developed secondary myeloid neoplasms, which are blood cancers that can occur after previous cancer treatments or due to genetic conditions. Participants receive up to two cycles of CPX-351 to try to a…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New Triple-Threat treatment tested for aggressive blood cancers
Disease control OngoingThis study is testing a combination of three drugs—azacitidine, venetoclax, and pevonedistat—for adults newly diagnosed with certain high-risk blood cancers. These include acute myeloid leukemia (AML) that developed from other blood disorders or prior cancer treatment, as well as…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial aims to improve survival for kids with High-Risk leukemia
Disease control OngoingThis large, late-stage trial is testing whether adding the drugs bortezomib or sorafenib to standard chemotherapy can better control a fast-growing blood cancer called acute myeloid leukemia (AML) in children and young adults. It focuses on patients with a specific high-risk gene…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC